Prof. Joshua D. Nosanchuk, Albert Einstein College of Medicine, Bronx, NY, USA
Prof. Karl Kuchler, Medical University of Vienna, Vienna, Austrin
Prof. Steven Almo, Albert Einstein College of Medicine, Bronx, NY, USA
Prof. Wilhelm Schaefer, Universität Hamburg, Biozentrum Klein Flottbek, Hamburg, Germany
Prof. Geraldine Butler, University of Dublin, Dublin, Ireland
Prof. Leonardo Nimrichter, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Prof. Jozef Nosek, Comenius University in Bratislava, Bratislava, Slovak Republic
Prof. Christophe d’Enfert, Institut Pasteur, Paris, France
Prof. Uwe Gross, Universitätsmedizin Göttingen, Göttingen, Germany
Prof. Hector M. Mora-Montes, Universidad de Guanajuato, Guanajuato, Mexico
Dr. Oscar Zaragoza, Instituto de Salud Carlos III, Madrid, Spain
Prof. Mihai G. Netea, Radboud University Nijmegen, Nijmegen, The Netherlands
Dr. Julian Naglik, King’s College, London, UK
Prof. Toni Gabaldón, Centre for Genomic Regulation (CRG), Barcelona, Spain
Prof. Dr. Bernhard Hube, Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie,Hans-Knöll-Institut (HKI), Jena, Germany
Prof. Ilse D. Jacobsen, , Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie, Hans-Knöll-Institut (HKI), Jena, Germany
Dr. Olga Heidingsfeld, Institute of Organic Chemistry and Biochemistry ASCR, Prague, Czech Republik
Prof. Arturo Casadevall, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.
